MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
The AZTEC Token Sale has successfully locked 12,500 ETH and will commence its public sale today.
PIPPIN's Counter-trend Rally Surpasses $200 Million in Market Cap, with a 24-hour Gain of 42.3%
GANA Payment has announced that they will fully compensate $3.1 million and will restart operations on December 2nd.
Solana Ecosystem Meme Coin KABUTO Surpasses $13 Million Market Cap Briefly, with a 327% Price Increase in 24 Hours
Japan's Interest Rate Hike Signal Triggers "Bloodletting" Worries in U.S. Markets, Fed's Rate Cut Prospect May Change
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]